Pacagen
Cambridge, United States · Founded 2023 · $13.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2C
- Website
- pacagen.com
- Total Funding
- $13.0M
- Last Round
- $13.0M Venture RoundJan 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biotech consumer brand making cat allergen neutralizing sprays and supplements using WhiskerBlock technology to eliminate Fel d 1 protein.
Summary
Pacagen is a Biotech company based in Cambridge, United States, founded in 2023. It has raised $13.0M in total across 1 round, most recently a $13.0M Venture Round in Jan 2024. Investors include Maveron, Bantam Group and Digitalis Ventures.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pacagen"><img src="https://indexed.vc/api/badge/company/pacagen" alt="Pacagen on Indexed.vc" width="260" height="76" /></a>